Creative Medical Technology Holdings Inc. (CELZ) - רווחיות גולמית

Creative Medical Technology (CELZ) specializes in regenerative therapy, having earned recognition in the treatment of reproductive pathologies. The company acquires clients through urological centers, although strict FDA oversight limits expansion. The model scales via the licensing of patents to clinics. Historical gross margins demonstrate effective cost management, while -3245.60 captures a new level mark.
פילוחי מדדים פיננסיים ומדדי שוק עבור creativemedicaltechnology.com (CELZ)

For Creative Medical Technology (CELZ), the gross margin reflects the efficiency of monetizing cellular technologies amid minimal geopolitical risks and the protection of patents in the US. By analyzing the current gross margin level, an investor can see the portion of revenue remaining after deducting direct production costs, which determines the business's ability to scale. Sharp fluctuations in this indicator signal cost instability, warning of the risk of capital overheating.